| pubmed-article:14962009 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14962009 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:14962009 | lifeskim:mentions | umls-concept:C0242694 | lld:lifeskim |
| pubmed-article:14962009 | lifeskim:mentions | umls-concept:C0027100 | lld:lifeskim |
| pubmed-article:14962009 | lifeskim:mentions | umls-concept:C0008932 | lld:lifeskim |
| pubmed-article:14962009 | lifeskim:mentions | umls-concept:C0597298 | lld:lifeskim |
| pubmed-article:14962009 | lifeskim:mentions | umls-concept:C0001721 | lld:lifeskim |
| pubmed-article:14962009 | lifeskim:mentions | umls-concept:C0205266 | lld:lifeskim |
| pubmed-article:14962009 | lifeskim:mentions | umls-concept:C1550605 | lld:lifeskim |
| pubmed-article:14962009 | lifeskim:mentions | umls-concept:C0456205 | lld:lifeskim |
| pubmed-article:14962009 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:14962009 | pubmed:dateCreated | 2004-2-13 | lld:pubmed |
| pubmed-article:14962009 | pubmed:abstractText | Pharmacological treatment with the beta2-adrenoceptor agonist clenbuterol is known to induce a slow-to-fast fibre type and myosin heavy chain (MHC) isoform transition in intact muscle. This study examined the sensitivity of regenerated soleus muscle to 4 weeks of clenbuterol treatment (2 mg kg-1 day-1). | lld:pubmed |
| pubmed-article:14962009 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14962009 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14962009 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14962009 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14962009 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14962009 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14962009 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14962009 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14962009 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:14962009 | pubmed:issn | 0001-6772 | lld:pubmed |
| pubmed-article:14962009 | pubmed:author | pubmed-author:SerrurierB... | lld:pubmed |
| pubmed-article:14962009 | pubmed:author | pubmed-author:BigardA XAX | lld:pubmed |
| pubmed-article:14962009 | pubmed:author | pubmed-author:BricoutV-AVA | lld:pubmed |
| pubmed-article:14962009 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14962009 | pubmed:volume | 180 | lld:pubmed |
| pubmed-article:14962009 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14962009 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14962009 | pubmed:pagination | 271-80 | lld:pubmed |
| pubmed-article:14962009 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:meshHeading | pubmed-meshheading:14962009... | lld:pubmed |
| pubmed-article:14962009 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:14962009 | pubmed:articleTitle | Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles. | lld:pubmed |
| pubmed-article:14962009 | pubmed:affiliation | Department of Human Factors, Centre de recherches du service de santé des armées, La Tronche Cedex, France. | lld:pubmed |
| pubmed-article:14962009 | pubmed:publicationType | Journal Article | lld:pubmed |
